Nebraska Legislature - Lobbyist Reporting Application

Clerk of the Legislature

Room 2014 State Capitol

PO Box 94604

Lincoln, NE 68509

(402) 471-2608

NEBRASKA LOBBYIST
STATEMENT of ACTIVITY

NADC FORM D

Submission Date: May 30, 2024

Each registered lobbyist shall file a Statement of Activity within 45 days after the end of a regular session of the Legislature. The statement must be filed even if the lobbyist engaged in no activity.
Any registered lobbyist who engages in lobbying activity in connection with a special session of the Legislature shall file a Statement of Activity within 45 days after the end of the special session. Late filing fees are $25.00 per day, not to exceed $750.00.
Lobbyists having more than one principal shall file a separate report for each principal.

ITEM 1

NATURE OF FILING (Check appropriate box)

For Calendar Year of

2024

Regular Session

Special Session

Amended Report

ITEM 2

NAME OF LOBBYIST AND PRINCIPAL

LOBBYIST

Lobbyist Name

Brandt, Horan, Hallstrom and Stilmock

Phone

(402) 269-2081

Address

PO Box 186

City

Syracuse

State

Zip

68446

PRINCIPAL

Principal Name

Nebraska Pharmacists Association

Office Phone

(402) 420-1500

Office Address (Street, Box, or Route)

6221 South 58th Street, Ste A

City

Lincoln

State

Zip

68516

List all the legislation upon which the lobbyist acted on behalf of the principal including bills, resolutions, amendments and procedural matters. Identify by number of bill, resolution, amendment or procedural matter and state the position taken. This statement should include a list of amendments or procedural matters which the lobbyist has acted upon for the principal, even if the lobbyist has not acted upon the bill or resolution from which the amendment or procedural matter arises.

Identify bill or resolution number	Identify amendment or procedural matter	Describe bill, resolution, amendment or procedural matter	Position taken
LB15		Change provisions of the Wage and Hour Act	Support
LB22		Decriminalize use and possession of marijuana	Neutral
LB142		Limit the amount an insured pays for prescription insulin drugs	Neutral
LB200		Adopt the Canadian Prescription Drug Importation Act	Oppose
LB204	AM1418	Provide for reimbursement for pharmacy dispensing fees under the medical assistance program	Support
LB204	FA235	Provide for reimbursement for pharmacy dispensing fees under the medical assistance program	Support
LB204	FA244	Provide for reimbursement for pharmacy dispensing fees under the medical assistance program	Support
LB210		Adopt the Prior Authorization Reform Act	Neutral
LB291		Require implicit bias or diversity, equity, and inclusion training for certain applicants and credential holders under the Uniform Credentialing Act	Neutral
LB307		Authorize syringe services programs in municipalities and counties and provide exceptions to penalties related to drug paraphernalia under the Uniform Controlled Substances Act	Neutral
LB333		Require a state plan amendment for coverage of family planning services under the Medical Assistance Act	Support
LB448		Prohibit certain provisions in a health plan in relation to clinician-administered drugs	Support
LB539		State intent regarding use of the Nebraska Health Care Cash Fund for the Tobacco Prevention and Control Program	Neutral
LB588		Adopt the Medicinal Cannabis Act	Support
LB595		Change supervision requirements under the Pharmacy Practice Act	Oppose
LB634		Adopt the Cannabis Control Act and the Cannabis Conviction Clean Slate Act	Neutral
LB663		State intent to appropriate funds to the Department of Health and Human Services	Neutral
LB680		Change provisions of the Parkinson’s Disease Registry Act	Support
LB778		Change the Pharmacy Benefit Manager Licensure and Regulation Act	Support
LB779		Limit the amount an insured pays for prescription insulin drugs	Neutral
LB795		Provide immunity for administration of naloxone or other federally approved opioid antagonists	Support
LB810		Adopt the Medical Ethics and Diversity Act	Support
LB833		Adopt the Prescription Drug Affordability Act	Oppose
LB852		Change provisions of the Medicare Supplement Insurance Minimum Standards Act	Neutral
LB857		Create the Nebraska Prenatal Plus Program, provide for use of the Medicaid Managed Care Excess Profit Fund, and change provisions relating to coverage of glucose monitors under the Medical Assistance Act	Support
LB892		Change provisions relating to controlled substances under the Uniform Controlled Substances Act	Support
LB896		Change provisions relating to telehealth consultations	Support
LB907		Require medicaid coverage for treatment of obesity	Support
LB913		Require a state plan amendment for postpartum coverage under the Children’s Health Insurance Program	Support
LB917		Require the establishment of a standard prior authorization process for health benefit plans and the approval and use of prior authorization forms	Support
LB933		Change medicaid coverage requirements for continuous glucose monitors	Support
LB972		Prohibit kratom as a controlled substance	Neutral
LB984		Prohibit certain actions relating to distribution of drugs by 340B entities	Support
LB990		Change provisions of the Pharmacy Benefit Manager Licensure and Regulation Act	Support
LB999		Change provisions of the Nebraska Hemp Farming Act and the Uniform Controlled Substances Act	Neutral
LB1035	AM2442	Adopt the Prescription Drug Donation Program Act	Support
LB1035	FA217	Adopt the Prescription Drug Donation Program Act	Support
LB1086		Eliminate the Department of Health and Human Services and create three departments	Neutral
LB1087		Adopt the Hospital Quality Assurance and Access Assessment Act and provide duties for the Nebraska Center for Nursing	Support
LB1094		Provide restrictions on insurance coverage of epinephrine injectors and inhalers	Support
LB1101		Provide requirements for the Public Health Early Admission Student Track Program and the Rural Health Opportunities Program and provide for tuition waivers	Support
LB1111		Require city-county health departments to obtain approval for directed health measures	Neutral
LB1128		Change provisions of the Opioid Prevention and Treatment Act	Support
LB1138		Provide an exemption from requirements for prescribers issuing prescriptions for controlled substances	Neutral
LB1148		Change requirements relating to insurance coverage of step therapy for certain drugs	Support
LB1171		Change verification requirements for pharmacy technicians	Support
LB1181		Change requirements relating to controlled substances, prescription drugs, pharmacists, and pharmacies as prescribed	Support
LB1215	AM2549	Adopt the Dietitian Licensure Compact and the Physician Assistant (PA) Licensure Compact, change provisions relating to prescriptions, death certificates, credentialing of barbers, nurses, pharmacies, pharmacy professionals, and certain health care facilities and services, treatment of individuals with communicable tuberculosis, and telehealth consultations, and provide for abstracts of death and coverage under the medical assistance program for certain breast pumps and lactation visits	Support
LB1232		Prohibit certain actions under the Pharmacy Benefit Manager Licensure and Regulation Act	Support
LB1274		Require insurance coverage of prosthetics and orthotics as prescribed	Neutral
LB1325		Allow pharmacists and local public health departments to distribute fentanyl strips as prescribed	Support
LB1355		Provide for release of certain patient data by an emergency medical service, change provisions of the Opioid Prevention and Treatment Act, and provide for state aid, research, first responder training, and overdose fatality review	Support
LB1376		Appropriate funds to the Department of Health and Human Services for prescription reimbursements	Support

I certify that all information presented in this form is accurate to the best of my knowledge.

Brandt, Horan, Hallstrom and Stilmock

Lobbyist Name

May 30, 2024

Date